193 related articles for article (PubMed ID: 34755644)
41. Individual risk of post-ivermectin serious adverse events in subjects infected with
Chesnais CB; Pion SD; Boullé C; Gardon J; Gardon-Wendel N; Fokom-Domgue J; Kamgno J; Boussinesq M
EClinicalMedicine; 2020 Nov; 28():100582. PubMed ID: 33294807
[TBL] [Abstract][Full Text] [Related]
42. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Tendongfor N; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Kah E; Enyong P; Taylor DW
Parasit Vectors; 2015 Apr; 8():202. PubMed ID: 25886166
[TBL] [Abstract][Full Text] [Related]
43. Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.
Niamsi-Emalio Y; Nana-Djeunga HC; Chesnais CB; Pion SDS; Tchatchueng-Mbougua JB; Boussinesq M; Basáñez MG; Kamgno J
Clin Infect Dis; 2021 Jun; 72(Suppl 3):S158-S164. PubMed ID: 33909066
[TBL] [Abstract][Full Text] [Related]
44. Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon.
Moutongo Mouandza R; Mourou JR; Moutombi Ditombi B; Roger Sibi Matotou H; Ekomi B; Bouyou-Akotet MK; Mawili-Mboumba DP
Am J Trop Med Hyg; 2023 Oct; 109(4):850-857. PubMed ID: 37339766
[TBL] [Abstract][Full Text] [Related]
45. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
[TBL] [Abstract][Full Text] [Related]
46. Excess mortality associated with loiasis: a retrospective population-based cohort study.
Chesnais CB; Takougang I; Paguélé M; Pion SD; Boussinesq M
Lancet Infect Dis; 2017 Jan; 17(1):108-116. PubMed ID: 27777031
[TBL] [Abstract][Full Text] [Related]
47. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
[TBL] [Abstract][Full Text] [Related]
48. Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
BMC Public Health; 2020 Aug; 20(1):1233. PubMed ID: 32787813
[TBL] [Abstract][Full Text] [Related]
49. A call for loiasis to be added to the WHO list of neglected tropical diseases.
Jacobsen KH; Andress BC; Bhagwat EA; Bryant CA; Chandrapu VR; Desmonts CG; Matthews TM; Ogunkoya A; Wheeler TJ; Williams AS
Lancet Infect Dis; 2022 Oct; 22(10):e299-e302. PubMed ID: 35500592
[TBL] [Abstract][Full Text] [Related]
50. Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
Johnson O; Giorgi E; Fronterrè C; Amoah B; Atsame J; Ella SN; Biamonte M; Ogoussan K; Hundley L; Gass K; Diggle PJ
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010189. PubMed ID: 35139080
[TBL] [Abstract][Full Text] [Related]
51. Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a
Brito M; Paulo R; Van-Dunem P; Martins A; Unnasch TR; Novak RJ; Jacob B; Stanton MC; Molyneux DH; Kelly-Hope LA
Parasite Epidemiol Control; 2017 Aug; 2(3):71-84. PubMed ID: 29774284
[TBL] [Abstract][Full Text] [Related]
52. Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping.
Kelly-Hope LA; Cano J; Stanton MC; Bockarie MJ; Molyneux DH
Parasit Vectors; 2014 Jul; 7():307. PubMed ID: 24992829
[TBL] [Abstract][Full Text] [Related]
53. Loiasis: African eye worm.
Padgett JJ; Jacobsen KH
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):983-9. PubMed ID: 18466939
[TBL] [Abstract][Full Text] [Related]
54. 'Slash and clear' vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages.
Siewe Fodjo JN; Vieri MK; Ngarka L; Njamnshi WY; Nfor LN; Mengnjo MK; Hendy A; Enyong PA; Palmer D; Basanez MG; Colebunders R; Njamnshi AK
BMJ Open; 2021 Sep; 11(9):e050341. PubMed ID: 34475178
[TBL] [Abstract][Full Text] [Related]
55. Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery.
Ayiseh RB; Mbah GE; Monya E; Ndi EM; Sakanari J; Lustigman S; Cho-Ngwa F
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011135. PubMed ID: 36827447
[TBL] [Abstract][Full Text] [Related]
56. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
[TBL] [Abstract][Full Text] [Related]
57. Validation of the rapid assessment procedure for loiasis (RAPLOA) in the Democratic Republic of Congo.
Wanji S; Akotshi DO; Mutro MN; Tepage F; Ukety TO; Diggle PJ; Remme JH
Parasit Vectors; 2012 Feb; 5():25. PubMed ID: 22300872
[TBL] [Abstract][Full Text] [Related]
58. Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.
Hassan AA; Akinsanya B; Iyase N; Owagboriaye FO
Korean J Parasitol; 2011 Jun; 49(2):153-9. PubMed ID: 21738271
[TBL] [Abstract][Full Text] [Related]
59. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
[TBL] [Abstract][Full Text] [Related]
60. Loiasis--a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon.
Takougang I; Meli J; Lamlenn S; Tatah PN; Ntep M
Ann Trop Med Parasitol; 2007 Mar; 101(2):151-60. PubMed ID: 17316501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
